Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Depression01:05

Long-term Depression

33.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.3K
Long-term Depression01:03

Long-term Depression

3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.4K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

40.0K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.0K
Depressants01:28

Depressants

428
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
428
Depression: Overview01:18

Depression: Overview

879
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
879
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.3K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.

Neuropsychiatric disease and treatment·2026
Same author

Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trial.

Journal of affective disorders·2026
Same author

Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.

The international journal of neuropsychopharmacology·2026
Same author

Rapid antidepressant potential of nitrous oxide: current state and major questions.

Molecular psychiatry·2025
Same author

Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report.

The Journal of clinical psychiatry·2025
Same author

An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression.

Journal of mood and anxiety disorders·2025

Related Experiment Video

Updated: Jan 31, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.4K

Neurostimulation for depression in epilepsy.

Charles R Conway1, Anita Udaiyar2, Steven C Schachter3

  • 1Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8134, Saint Louis, MO 63110, United States.

Epilepsy & Behavior : E&B
|December 19, 2018
PubMed
Summary

Major depressive disorder is a common comorbidity in epilepsy, affecting 40% of patients. Neuromodulation techniques like electroconvulsive therapy (ECT) and vagus nerve stimulation (VNS) show promise for treatment-resistant depression in epilepsy.

Keywords:
Electroconvulsive therapyEpilepsyMajor depressionNeuromodulationRepetitive transcranial magnetic stimulationVagus nerve stimulation

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.6K
Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring
11:28

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring

Published on: June 13, 2025

1.3K

Related Experiment Videos

Last Updated: Jan 31, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.4K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.6K
Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring
11:28

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring

Published on: June 13, 2025

1.3K

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Epilepsy frequently co-occurs with psychiatric conditions, impacting patient prognosis.
  • Major depressive disorder (MDD) is the most prevalent psychiatric comorbidity in epilepsy, affecting approximately 40% of individuals.
  • Underdiagnosis and undertreatment of mood symptoms in epilepsy are common, yet crucial for improving patient outcomes.

Purpose of the Study:

  • To review the role of neuromodulation techniques in managing depression in patients with epilepsy.
  • To highlight the potential of electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), and repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression in this population.

Main Methods:

  • This is a review article.
  • The review discusses existing literature on neuromodulation for comorbid depression in epilepsy.
  • Specific focus on electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), and repetitive transcranial magnetic stimulation (rTMS).

Main Results:

  • Major depressive disorder is highly prevalent in epilepsy patients.
  • Conventional psychiatric treatments may not always be effective for depression in epilepsy.
  • Neuromodulation techniques offer potential therapeutic options when standard treatments fail.

Conclusions:

  • Managing psychiatric comorbidities, particularly depression, is essential for improving the overall outcomes of epilepsy.
  • Neuromodulation techniques such as ECT, VNS, and rTMS represent promising avenues for treating depression in epilepsy patients who do not respond to conventional therapies.
  • Further research and clinical application of these techniques are warranted.